Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity

Background Cancer immunotherapy has taken center stage in cancer treatment. However, the current immunotherapies only benefit a small proportion of patients with cancer, necessitating better understanding of the mechanisms of tumor immune evasion and improved cancer immunotherapy strategies. Regulat...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Yuan Li, Yi Zheng, Phuong Nguyen, Ting Wen, Anil G Jegga, Khalid W Kalim, Jun-Qi Yang, Mark Wunderlich, Vishnu Modur, Ashley Kuenzi Davis, Ravinder Verma, Qing Richard Lu, Fukun Guo
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMJ Publishing Group 2022-11-01
Serier:	Journal for ImmunoTherapy of Cancer
Online adgang:	https://jitc.bmj.com/content/10/11/e004806.full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!